These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20230266)

  • 1. Improving heart failure outcomes with pharmacist-physician collaboration: how close are we?
    Kalisch LM; Roughead EE; Gilbert AL
    Future Cardiol; 2010 Mar; 6(2):255-68. PubMed ID: 20230266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study.
    Roughead EE; Barratt JD; Ramsay E; Pratt N; Ryan P; Peck R; Killer G; Gilbert AL
    Circ Heart Fail; 2009 Sep; 2(5):424-8. PubMed ID: 19808372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review.
    Ponniah A; Anderson B; Shakib S; Doecke CJ; Angley M
    J Clin Pharm Ther; 2007 Aug; 32(4):343-52. PubMed ID: 17635336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist and physician collaboration in the patient's home.
    Amruso NA; O'Neal ML
    Ann Pharmacother; 2004 Jun; 38(6):1048-52. PubMed ID: 15113983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interventions to improve the management of diabetes mellitus in primary health care and outpatient community settings].
    Hansen LJ; Drivsholm TB
    Ugeskr Laeger; 2002 Jan; 164(5):607-9. PubMed ID: 11871208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician-pharmacist collaborative care in dyslipidemia management: the perception of clinicians and patients.
    Lalonde L; Hudon E; Goudreau J; Bélanger D; Villeneuve J; Perreault S; Blais L; Lamarre D
    Res Social Adm Pharm; 2011 Sep; 7(3):233-45. PubMed ID: 21272548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boost outcomes--add a clinical pharmacist to the team.
    Clin Resour Manag; 2001 Jan; 2(1):6-10, 1. PubMed ID: 11215356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist roles in the management of patients with type 2 diabetes.
    Sisson E; Kuhn C
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S41-5. PubMed ID: 19801364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial.
    Holland R; Brooksby I; Lenaghan E; Ashton K; Hay L; Smith R; Shepstone L; Lipp A; Daly C; Howe A; Hall R; Harvey I
    BMJ; 2007 May; 334(7603):1098. PubMed ID: 17452390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home-based medication review in a high risk elderly population in primary care--the POLYMED randomised controlled trial.
    Lenaghan E; Holland R; Brooks A
    Age Ageing; 2007 May; 36(3):292-7. PubMed ID: 17387123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting.
    Makowsky MJ; Schindel TJ; Rosenthal M; Campbell K; Tsuyuki RT; Madill HM
    J Interprof Care; 2009 Mar; 23(2):169-84. PubMed ID: 19234987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group.
    Krumholz HM; Currie PM; Riegel B; Phillips CO; Peterson ED; Smith R; Yancy CW; Faxon DP;
    Circulation; 2006 Sep; 114(13):1432-45. PubMed ID: 16952985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist's identity development within multidisciplinary primary health care teams in Ontario; qualitative results from the IMPACT project.
    Pottie K; Haydt S; Farrell B; Kennie N; Sellors C; Martin C; Dolovich L;
    Res Social Adm Pharm; 2009 Dec; 5(4):319-26. PubMed ID: 19962675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of chronic disease management algorithms in Australian community pharmacies.
    Morrissey H; Ball P; Jackson D; Pilloto L; Nielsen S
    Res Social Adm Pharm; 2015; 11(2):176-96. PubMed ID: 25035062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist's role in management of hypertensive patients in an ambulatory care clinic.
    Reinders TP; Rush DR; Baumgartner RP; Graham AW
    Am J Hosp Pharm; 1975 Jun; 32(6):590-4. PubMed ID: 1155472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care professionals in a heart failure team.
    Jaarsma T
    Eur J Heart Fail; 2005 Mar; 7(3):343-9. PubMed ID: 15718174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life.
    Isetts BJ; Schondelmeyer SW; Heaton AH; Wadd WB; Hardie NA; Artz MB
    Res Social Adm Pharm; 2006 Mar; 2(1):129-42. PubMed ID: 17138505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How physician and community pharmacist perceptions of the community pharmacist role in Australian primary care influence the quality of collaborative chronic disease management.
    Rieck A; Pettigrew S
    Qual Prim Care; 2013; 21(2):105-11. PubMed ID: 23735691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.